XML 13 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
CHINA GEWANG BIOTECHNOLOGY, INC.- Consolidated Balance Sheets Unaudited - USD ($)
Feb. 29, 2016
Nov. 30, 2015
Current Assets:    
Cash $ 14,180,591 $ 8,669,034
Accounts receivable 294,594 267,868
Inventory, net 40,157 156,778
Prepaid expenses 269,339 201,369
Total current assets 14,784,681 9,295,049
Property, plant and equipment, net 132,530 65,860
Total Assets $ 14,917,211 $ 9,360,909
Current Liabilities:    
Advance from customer
Accounts payable
Taxes payable $ 73,601 $ 64,153
Payroll payable
Accrued expenses and other payable $ 64,644 $ 175,086
Loans from stockholder 185,917 166,106
TOTAL CURRENT LIABILITIES 324,162 405,345
Stockholders' equity:    
Common stock [1] 57,500 45,500
Additional paid-in capital 11,986,943 6,525,743
Retained earnings 2,565,577 2,270,416
Statutory reserve fund 318,791 281,766
Other comprehensive (loss) income (429,116) (252,022)
Sub-total 14,499,695 8,871,403
Non-controlling interest 93,354 84,161
Total Stockholders' equity 14,593,049 8,955,564
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 14,917,211 $ 9,360,909
[1] $0.001 par value, 75,000,000 shares authorized; 57,500,000 and 45,500,000 shares issued and outstanding as of February 29, 2016 and November 30, 2015 respectively